11 Amendments of Gesine MEISSNER related to 2017/2254(INI)
Amendment 26 #
Motion for a resolution
Recital A a (new)
Recital A a (new)
Amendment 45 #
Motion for a resolution
Recital C
Recital C
C. whereas healthcare-associated infections (HAI) are often dueoccur due to lacking prevention measures which lead to antibiotic-resistant bacteria; whereas the European Centre for Disease Prevention and Control (ECDC) estimates that approximately 4 million patients acquire a HAI each year in the EU and that approximately 37 000 deaths result directly from these infections;
Amendment 117 #
Motion for a resolution
Paragraph 2 a (new)
Paragraph 2 a (new)
2a. Calls on the Commission and Member States to distinguish between livestock and pets particularly in the design of monitoring and assessment of the use of antimicrobials in veterinary medicine, as well as in the design of measures to address their use;
Amendment 172 #
6a. Stresses that compliance to infection control guidelines, integrating targets for infection rate reductions and supporting best practice all help address patient safety in the hospital environment;
Amendment 228 #
Motion for a resolution
Paragraph 11
Paragraph 11
11. Calls Stresses that particularly in rural areas it is challenging to respond the Commission and the Member States to restrict or stopo livestock health issues in good time and that therefore in some regions it has proven irreplaceable to allow veterinarians to directly supply antibiotics; calls on the Commission and the Member States to only address the sale of antibiotics by those doctors or veterinarians who prescribe them in a way that still allows a sufficiently fast supply of antibiotics for veterinary use in livestock;
Amendment 275 #
Motion for a resolution
Paragraph 13 a (new)
Paragraph 13 a (new)
Amendment 287 #
Motion for a resolution
Paragraph 14
Paragraph 14
Amendment 320 #
Motion for a resolution
Paragraph 15 a (new)
Paragraph 15 a (new)
15 a. Urges the European Commission to consider a new legislative framework to stimulate the development of new antimicrobials for humans, as already requested by the European Parliament on 10 March 2016 on the proposal for a regulation of the European Parliament and of the Council on veterinary medicinal products and in the parliamentary resolution (2015) 0197 of19 May 2015; notes that the Commission “One Health” Action Plan against AMR also commits itself to “analyse EU regulatory tools and incentives - in particular orphan and paediatric legislation – to use them for novel antimicrobials".
Amendment 347 #
Motion for a resolution
Paragraph 18 a (new)
Paragraph 18 a (new)
18 a. Welcomes recent cross-border research projects into antimicrobial stewardship and the prevention of infection, such as the EU-funded i-4-1- Health Interreg project; calls on the Commission to increase research funding for measures to prevent healthcare- associated infections (HAI);
Amendment 359 #
Motion for a resolution
Paragraph 21
Paragraph 21
21. Calls on the Commission and the Member States to support the implementation of new economic models, pilot projects and incentives to boost the development of new diagnostics, antibiotics, alternamedicines and medical devices; believing that that these are meaningful when they are sustainable over the long term, target key public prioritives, and vaccinessupport appropriate medicinal use;
Amendment 371 #
Motion for a resolution
Paragraph 21 a (new)
Paragraph 21 a (new)
21 a. Encouraging the uptake of cost- effectiveness technologies that reduce the impact of health associated infections (HAIs) in hospitals and help preventing the spread of multi-resistant microorganisms